Some economics on personalized and predictive medicine

[1] Gibson WM(1971)Can personalized medicine survive? Can Fam Physician 17 29-88

[2] Antoñanzas F(2012)Genetic testing in the European Union: does economic evaluation matter? Eur J Health Econ 12 651-662

[3] Rodríguez-Ibeas R(2012)Enhancing the health economic value of retrospective and prospective real-world studies with pharmacogenomic testing: opportunities and challenges associated with an integrated personalized medicine approach Value Health 15 A159-A160

[4] Hutter MF(2009)Will personalized medicine help in ‘transforming’ the business of healthcare? Pers Med 6 555-565

[5] Lorente R(2013)The economic evaluation of personalised oncology medicines: ethical challenges Med J Aust 199 471-473

[6] Juárez C(2013)Personalized medicine. medical, ethical, legal, and economic analysis Ethik in Der Med 25 169-172

[7] Pinillos M(2013)The faces of personalized medicine: a framework for understanding its meaning and scope Value Health 16 54-59

[8] Payne KA(2007)Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers Nat Rev Drug Discov 6 287-293

[9] Frueh FW(2013)Personalized oncology: recent advances and future challenges Metabolism 62 S11-S14

[10] Sohal J(2010)Personalized medicine: factors influencing reimbursement Health Policy 94 91-100

[1] Gibson WM(1971)Can personalized medicine survive? Can Fam Physician 17 29-88

[2] Antoñanzas F(2012)Genetic testing in the European Union: does economic evaluation matter? Eur J Health Econ 12 651-662

[3] Rodríguez-Ibeas R(2012)Enhancing the health economic value of retrospective and prospective real-world studies with pharmacogenomic testing: opportunities and challenges associated with an integrated personalized medicine approach Value Health 15 A159-A160

[4] Hutter MF(2009)Will personalized medicine help in ‘transforming’ the business of healthcare? Pers Med 6 555-565

[5] Lorente R(2013)The economic evaluation of personalised oncology medicines: ethical challenges Med J Aust 199 471-473

[6] Juárez C(2013)Personalized medicine. medical, ethical, legal, and economic analysis Ethik in Der Med 25 169-172

[7] Pinillos M(2013)The faces of personalized medicine: a framework for understanding its meaning and scope Value Health 16 54-59

[8] Payne KA(2007)Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers Nat Rev Drug Discov 6 287-293

[9] Frueh FW(2013)Personalized oncology: recent advances and future challenges Metabolism 62 S11-S14

[10] Sohal J(2010)Personalized medicine: factors influencing reimbursement Health Policy 94 91-100